Victory Capital Management Inc Celyad Oncology Sa Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021
SELL
$3.88 - $5.25 $310,019 - $419,485
-79,902 Closed
0 $0
Q2 2021

Aug 03, 2021
SELL
$5.17 - $7.1 $3.46 Million - $4.76 Million
-670,014 Reduced 89.35%
79,902 $419,000
Q1 2021

May 04, 2021
SELL
$7.0 - $8.75 $286,230 - $357,787
-40,890 Reduced 5.17%
749,916 $5.23 Million
Q4 2020

Feb 01, 2021
SELL
$7.13 - $9.95 $314,867 - $439,401
-44,161 Reduced 5.29%
790,806 $6.17 Million
Q3 2020

Nov 09, 2020
BUY
$9.17 - $11.03 $460,581 - $554,003
50,227 Added 6.4%
834,967 $8.33 Million
Q2 2020

Aug 07, 2020
SELL
$7.07 - $12.46 $1.47 Million - $2.59 Million
-208,118 Reduced 20.96%
784,740 $8.52 Million
Q1 2020

May 04, 2020
SELL
$4.18 - $12.42 $27,508 - $81,736
-6,581 Reduced 0.66%
992,858 $7.26 Million
Q4 2019

Feb 06, 2020
SELL
$8.46 - $12.74 $51,851 - $78,083
-6,129 Reduced 0.61%
999,439 $10.4 Million
Q4 2019

Feb 04, 2020
BUY
$8.46 - $12.74 $439,133 - $661,295
51,907 Added 5.44%
1,005,568 $10.9 Million
Q3 2019

Nov 12, 2019
BUY
$9.6 - $14.88 $2.53 Million - $3.92 Million
263,480 Added 38.18%
953,661 $9.62 Million
Q2 2019

Aug 15, 2019
BUY
$10.94 - $22.64 $195,279 - $404,124
17,850 Added 2.65%
690,181 $7.92 Million
Q1 2019

May 03, 2019
BUY
$19.76 - $24.56 $513,364 - $638,068
25,980 Added 4.02%
672,331 $13.7 Million
Q4 2018

Feb 05, 2019
BUY
$16.0 - $28.17 $403,024 - $709,574
25,189 Added 4.06%
646,351 $11.7 Million
Q3 2018

Nov 01, 2018
BUY
$26.49 - $31.86 $454,568 - $546,717
17,160 Added 2.84%
621,162 $16.4 Million
Q2 2018

Aug 02, 2018
BUY
$26.05 - $35.15 $4.65 Million - $6.27 Million
178,380 Added 41.91%
604,002 $18.7 Million
Q1 2018

May 04, 2018
SELL
$34.1 - $47.52 $623,348 - $868,665
-18,280 Reduced 4.12%
425,622 $14.6 Million
Q4 2017

Feb 01, 2018
BUY
$35.81 - $64.0 $4.25 Million - $7.59 Million
118,590 Added 36.45%
443,902 $19.5 Million
Q3 2017

Oct 27, 2017
SELL
$40.0 - $57.3 $1.89 Million - $2.71 Million
-47,280 Reduced 12.69%
325,312 $18.2 Million
Q2 2017

Aug 07, 2017
BUY
N/A
372,592
372,592 $15.8 Million

About Celyad Oncology SA

CYAD Quotes by TradingView
  • Ticker CYAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,594,000
  • Market Cap $11.7M
  • Description
  • Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cance...
More about CYAD
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email